{"id":11809,"date":"2023-05-08T12:23:06","date_gmt":"2023-05-08T10:23:06","guid":{"rendered":"https:\/\/ggba.swiss\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/"},"modified":"2023-07-04T13:44:18","modified_gmt":"2023-07-04T11:44:18","slug":"novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/","title":{"rendered":"Novostia lance les premiers essais sur l\u2019homme de sa valve cardiaque artificielle"},"content":{"rendered":"\n

Novostia<\/a> est une entreprise de phase clinique ax\u00e9e sur le d\u00e9veloppement de technologies innovantes de valves cardiaques artificielles. Leur mission est d’am\u00e9liorer la qualit\u00e9 de vie des patients souffrant de maladies des valves cardiaques en \u00e9liminant les inconv\u00e9nients associ\u00e9s aux technologies actuelles de remplacement de valves.<\/p>\n

Les maladies des valves cardiaques touchent plus de 100 millions de personnes dans le monde, des centaines de milliers de patients subissant chaque ann\u00e9e des interventions de remplacement de valves cardiaques. Les technologies existantes pr\u00e9sentent de s\u00e9rieux inconv\u00e9nients, tels que la n\u00e9cessit\u00e9 d’un traitement anticoagulant \u00e0 vie ou d’autres remplacements en raison de la durabilit\u00e9 limit\u00e9e des valves. En utilisant une conception brevet\u00e9e unique et un polym\u00e8re biocompatible haute performance, la valve cardiaque artificielle de Novostia vise \u00e0 fonctionner sans n\u00e9cessiter de traitement anticoagulant et \u00e0 offrir une durabilit\u00e9 accrue pour les patients de tous \u00e2ges.<\/p>\n

Novostia a \u00e9t\u00e9 fond\u00e9e en avril 2017 \u00e0 Neuch\u00e2tel, une r\u00e9gion r\u00e9put\u00e9e pour ses technologies innovantes et ses industries biom\u00e9dicales. L’entreprise a \u00e9t\u00e9 cr\u00e9\u00e9e dans l’incubateur Microcity<\/a>, qui lui a fourni un environnement propice au d\u00e9veloppement de sa technologie r\u00e9volutionnaire de valves cardiaques artificielles.<\/p>\n

Aujourd’hui situ\u00e9e sur le campus du Biop\u00f4le<\/a>, Novostia utilisera les fonds de la s\u00e9rie A pour lancer les premiers essais sur l’homme de sa valve cardiaque artificielle innovante. Un tour de financement de s\u00e9rie B est pr\u00e9vu pour cet \u00e9t\u00e9, apr\u00e8s une r\u00e9\u00e9valuation de l’entreprise. Les fonds de la s\u00e9rie B serviront \u00e0 achever l’\u00e9tude pilote et \u00e0 lancer l’\u00e9tude pivot suivante, qui inclura environ 60 patients pour la premi\u00e8re et 500 pour la seconde. Ces \u00e9tudes devraient fournir les donn\u00e9es n\u00e9cessaires \u00e0 Novostia pour obtenir le marquage CE et l’autorisation de mise sur le march\u00e9.<\/p>\n

R\u00e9volutionner le remplacement des valves cardiaques<\/h4>\n

Les tests exp\u00e9rimentaux, num\u00e9riques et sur animaux ont montr\u00e9 que la valve de Novostia fonctionne physiologiquement comme une valve cardiaque humaine native. Elle ne produit pas de jets de reflux \u00e0 haute v\u00e9locit\u00e9, n’entra\u00eene pas de r\u00e9ponse h\u00e9mostatique et devrait fonctionner sans n\u00e9cessiter de traitement anticoagulant. Contrairement aux valves en tissu, dont la durabilit\u00e9 est limit\u00e9e, en particulier chez les patients plus jeunes, la valve Novostia est con\u00e7ue structurellement pour durer toute une vie pour les patients de tous \u00e2ges, r\u00e9duisant ainsi consid\u00e9rablement le risque de r\u00e9intervention.<\/p>\n

Cette technologie innovante de valve cardiaque artificielle a le potentiel d’am\u00e9liorer significativement la qualit\u00e9 de vie des patients, en particulier pour les enfants et les jeunes adultes, tout en r\u00e9duisant les co\u00fbts du syst\u00e8me de sant\u00e9. Le succ\u00e8s du tour de financement de s\u00e9rie A est une \u00e9tape essentielle pour apporter cette innovation tant attendue aux patients et aux m\u00e9decins du monde entier.<\/p>\n","protected":false},"excerpt":{"rendered":"

Novostia, une entreprise de phase clinique ax\u00e9e sur le d\u00e9veloppement de valves cardiaques artificielles r\u00e9volutionnaires, a r\u00e9cemment annonc\u00e9 la r\u00e9ussite de son tour de financement de s\u00e9rie A de EUR 2,5 millions.<\/p>\n","protected":false},"author":3,"featured_media":11810,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1041,1060,1082],"class_list":["post-11809","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-financing-fr","tag-medtech-fr","tag-technology-park-fr"],"acf":[],"yoast_head":"\nNovostia lance les premiers essais sur l\u2019homme de sa valve cardiaque artificielle - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novostia lance les premiers essais sur l\u2019homme de sa valve cardiaque artificielle - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"Novostia, une entreprise de phase clinique ax\u00e9e sur le d\u00e9veloppement de valves cardiaques artificielles r\u00e9volutionnaires, a r\u00e9cemment annonc\u00e9 la r\u00e9ussite de son tour de financement de s\u00e9rie A de EUR 2,5 millions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-08T10:23:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:44:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Novostia-Valve-630x380-1-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"Novostia lance les premiers essais sur l\u2019homme de sa valve cardiaque artificielle\",\"datePublished\":\"2023-05-08T10:23:06+00:00\",\"dateModified\":\"2023-07-04T11:44:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/\"},\"wordCount\":506,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Novostia-Valve-630x380-1-2.png\",\"keywords\":[\"Financing\",\"Medtech\",\"Technology Park\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/\",\"name\":\"Novostia lance les premiers essais sur l\u2019homme de sa valve cardiaque artificielle - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Novostia-Valve-630x380-1-2.png\",\"datePublished\":\"2023-05-08T10:23:06+00:00\",\"dateModified\":\"2023-07-04T11:44:18+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Novostia-Valve-630x380-1-2.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Novostia-Valve-630x380-1-2.png\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novostia lance les premiers essais sur l\u2019homme de sa valve cardiaque artificielle\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novostia lance les premiers essais sur l\u2019homme de sa valve cardiaque artificielle - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/","og_locale":"fr_FR","og_type":"article","og_title":"Novostia lance les premiers essais sur l\u2019homme de sa valve cardiaque artificielle - Greater Geneva Bern area","og_description":"Novostia, une entreprise de phase clinique ax\u00e9e sur le d\u00e9veloppement de valves cardiaques artificielles r\u00e9volutionnaires, a r\u00e9cemment annonc\u00e9 la r\u00e9ussite de son tour de financement de s\u00e9rie A de EUR 2,5 millions.","og_url":"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-05-08T10:23:06+00:00","article_modified_time":"2023-07-04T11:44:18+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Novostia-Valve-630x380-1-2.png","type":"image\/png"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"Novostia lance les premiers essais sur l\u2019homme de sa valve cardiaque artificielle","datePublished":"2023-05-08T10:23:06+00:00","dateModified":"2023-07-04T11:44:18+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/"},"wordCount":506,"image":{"@id":"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Novostia-Valve-630x380-1-2.png","keywords":["Financing","Medtech","Technology Park"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/","url":"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/","name":"Novostia lance les premiers essais sur l\u2019homme de sa valve cardiaque artificielle - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Novostia-Valve-630x380-1-2.png","datePublished":"2023-05-08T10:23:06+00:00","dateModified":"2023-07-04T11:44:18+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Novostia-Valve-630x380-1-2.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Novostia-Valve-630x380-1-2.png","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/novostia-lance-les-premiers-essais-sur-lhomme-de-sa-valve-cardiaque-artificielle\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Novostia lance les premiers essais sur l\u2019homme de sa valve cardiaque artificielle"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=11809"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11809\/revisions"}],"predecessor-version":[{"id":18365,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11809\/revisions\/18365"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/11810"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=11809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=11809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=11809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}